These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 17084083)
21. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3. Day JM; Tutill HJ; Foster PA; Bailey HV; Heaton WB; Sharland CM; Vicker N; Potter BV; Purohit A; Reed MJ Mol Cell Endocrinol; 2009 Mar; 301(1-2):251-8. PubMed ID: 18786604 [TBL] [Abstract][Full Text] [Related]
22. Cellular protection by erythropoietin: new therapeutic implications? Joyeux-Faure M J Pharmacol Exp Ther; 2007 Dec; 323(3):759-62. PubMed ID: 17717190 [TBL] [Abstract][Full Text] [Related]
23. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone. Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936 [TBL] [Abstract][Full Text] [Related]
24. Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation. Harmange JC; Weiss MM; Germain J; Polverino AJ; Borg G; Bready J; Chen D; Choquette D; Coxon A; DeMelfi T; DiPietro L; Doerr N; Estrada J; Flynn J; Graceffa RF; Harriman SP; Kaufman S; La DS; Long A; Martin MW; Neervannan S; Patel VF; Potashman M; Regal K; Roveto PM; Schrag ML; Starnes C; Tasker A; Teffera Y; Wang L; White RD; Whittington DA; Zanon R J Med Chem; 2008 Mar; 51(6):1649-67. PubMed ID: 18324761 [TBL] [Abstract][Full Text] [Related]
25. A new method for in-silico drug screening and similarity search using molecular dynamics maximum volume overlap (MD-MVO) method. Fukunishi Y; Nakamura H J Mol Graph Model; 2009 Jan; 27(5):628-36. PubMed ID: 19046907 [TBL] [Abstract][Full Text] [Related]
26. Critical importance of the nine-membered F ring of ciguatoxin for potent bioactivity: total synthesis and biological evaluation of F-ring-modified analogues. Inoue M; Lee N; Miyazaki K; Usuki T; Matsuoka S; Hirama M Angew Chem Int Ed Engl; 2008; 47(45):8611-4. PubMed ID: 18846538 [No Abstract] [Full Text] [Related]
27. Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities. Corona P; Loriga M; Costi MP; Ferrari S; Paglietti G Eur J Med Chem; 2008 Jan; 43(1):189-203. PubMed ID: 17532099 [TBL] [Abstract][Full Text] [Related]
28. Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as novel antiproliferative agents: exploration of core and headpiece structure-activity relationships. Powell D; Gopalsamy A; Wang YD; Zhang N; Miranda M; McGinnis JP; Rabindran SK Bioorg Med Chem Lett; 2007 Mar; 17(6):1641-5. PubMed ID: 17275298 [TBL] [Abstract][Full Text] [Related]
30. An erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cells. Jeong JY; Hoxhaj G; Socha AL; Sytkowski AJ; Feldman L Mol Cancer Res; 2009 Jul; 7(7):1150-7. PubMed ID: 19567780 [TBL] [Abstract][Full Text] [Related]
31. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341 [TBL] [Abstract][Full Text] [Related]
32. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165 [TBL] [Abstract][Full Text] [Related]
33. Erythropoietin in cardiac disease: new features of an old drug. Ruifrok WP; de Boer RA; Westenbrink BD; van Veldhuisen DJ; van Gilst WH Eur J Pharmacol; 2008 May; 585(2-3):270-7. PubMed ID: 18407263 [TBL] [Abstract][Full Text] [Related]
34. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design. Fukunishi Y; Mashimo T; Orita M; Ohno K; Nakamura H J Chem Inf Model; 2009 Apr; 49(4):925-33. PubMed ID: 19354203 [TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer. Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160 [TBL] [Abstract][Full Text] [Related]
37. Advances towards the development of ATP-competitive small-molecule inhibitors of the insulin-like growth factor receptor (IGF-IR). Hubbard RD; Wilsbacher JL ChemMedChem; 2007 Jan; 2(1):41-6. PubMed ID: 17089440 [No Abstract] [Full Text] [Related]
38. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring. Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892 [TBL] [Abstract][Full Text] [Related]
39. A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors. Lin WH; Song JS; Chang TY; Chang CY; Fu YN; Yeh CL; Wu SH; Huang YW; Fang MY; Lien TW; Hsieh HP; Chao YS; Huang SF; Tsai SF; Wang LM; Hsu JT; Chen YR Anal Biochem; 2008 Jun; 377(1):89-94. PubMed ID: 18358823 [TBL] [Abstract][Full Text] [Related]
40. Discovery of tetrahydrotetramethylnaphthalene analogs as adult T-cell leukemia cell-selective proliferation inhibitors in a small chemical library constructed based on multi-template hypothesis. Nakamura M; Hamasaki T; Tokitou M; Baba M; Hashimoto Y; Aoyama H Bioorg Med Chem; 2009 Jul; 17(13):4740-6. PubMed ID: 19443225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]